Literature DB >> 16891278

Extreme thrombocytosis predicts Kawasaki disease in infants.

Lise E Nigrovic1, Peter A Nigrovic, Marvin B Harper, Vincent W Chiang.   

Abstract

Infants with Kawasaki disease are at high risk of developing life-threatening coronary complications, yet may elude timely diagnosis because they often lack the full complement of classic clinical features. We retrospectively studied 26,540 children 1 year of age or less who were evaluated at a tertiary care pediatric emergency department in whom a platelet count was performed. Among those infants with fever without a source identified, 8.5% with platelet counts of 800,000 cells/mm(3) or greater had Kawasaki disease compared to 0.4% with platelet counts of less than 800,000 cells/mm(3) (likelihood ratio for Kawasaki disease was 17 [95% confidence interval, 8-34]). Because many infants present atypically, Kawasaki disease should be considered in all children of 1 year or less with prolonged fever, extreme elevation of the platelet count, and no compelling alternative diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 16891278     DOI: 10.1177/0009922806289621

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  8 in total

1.  N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.

Authors:  Hyuksool Kwon; Jin Hee Lee; Jae Yun Jung; Young Ho Kwak; Do Kyun Kim; Jin Hee Jung; Ikwan Chang; Kyuseok Kim
Journal:  Eur J Pediatr       Date:  2016-10-31       Impact factor: 3.183

2.  Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis.

Authors:  Song Xiu-Yu; Huang Jia-Yu; Hong Qiang; Dai Shu-Hui
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Do predictors of incomplete Kawasaki disease exist for infants?

Authors:  Sol Ji No; Dong Ouk Kim; Kyong Min Choi; Lucy Youngmin Eun
Journal:  Pediatr Cardiol       Date:  2012-09-22       Impact factor: 1.655

Review 4.  Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Authors:  Lung Chang; Horng-Woei Yang; Tang-Yu Lin; Kuender D Yang
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

Review 5.  Essential Thrombocythemia in Children and Adolescents.

Authors:  Maria Caterina Putti; Irene Bertozzi; Maria Luigia Randi
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

6.  Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients.

Authors:  Christopher S Thom; Emily Echevarria; Ashley D Osborne; Leah Carr; Kathryn M Rubey; Elizabeth Salazar; Danielle Callaway; Thomas Pawlowski; Matthew Devine; Stacey Kleinman; Char Witmer; John Flibotte; Michele P Lambert
Journal:  J Thromb Haemost       Date:  2020-10-21       Impact factor: 16.036

Review 7.  Kawasaki disease in infants.

Authors:  Jung Sook Yeom; Hyang Ok Woo; Ji Sook Park; Eun Sil Park; Ji-Hyun Seo; Hee-Shang Youn
Journal:  Korean J Pediatr       Date:  2013-09-30

Review 8.  C1 esterase inhibitor and the contact system in COVID-19.

Authors:  Timothy M Thomson; Emily Toscano-Guerra; Ernesto Casis; Rosanna Paciucci
Journal:  Br J Haematol       Date:  2020-07-28       Impact factor: 8.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.